相关实验视频
Updated: Sep 13, 2025

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.3K
中枢神经系统瘤的低分离放射疗法:2025年当前的想法
Agathe Margulies1, Anaïs Stefani1, Delphine Antoni2
1Department of Radiotherapy, Institut de cancérologie de Lorraine, 6, avenue de Bourgogne, 54519 Vandœuvre-lès-Nancy, France.
概括
低分离放射治疗越来越多地用于脑瘤,特别是在再辐射的情况下. 精心规划是必不可少的,但这种技术不适合所有中枢神经系统瘤.
科学领域:
- 神经瘤学神经瘤学
- 辐射瘤学 辐射瘤学
背景情况:
- 对中枢神经系统 (CNS) 瘤的低分离放射治疗的应用正在增长.
- 这种扩张在很大程度上是由于在治疗神经性恶性瘤中对再辐射的需求日益增加而导致的.
研究的目的:
- 为中枢神经系统瘤使用低分离放射治疗提供全面的反思.
- 解决关于这种治疗方式的理由,指示,技术考虑,时间和禁忌的关键问题.
主要方法:
- 这项研究涉及对神经瘤的低分离放射治疗进行反射分析.
- 用临床示例来说明这篇文章中探讨的五个核心问题.
- 对患者和瘤选择的建议和说明进行了审查.
主要成果:
- 探讨了低分离的理由和好处,强调了其潜在的优势.
- 讨论了特定患者和瘤类型中低分离的适用性.
- 详细介绍了关键的治疗规划考虑因素,特别是对于再照射和并发性全身疗法.
- 检查了低分离放射治疗 (独家,联合或连续) 的最佳时间.
- 确定了对某些中枢神经系统瘤的潜在禁忌和低分离的限制.
结论:
- 低分离辐射疗法对特定的中枢神经系统瘤情景,特别是再辐射有好处.
- 仔细选择患者,量身定制的治疗计划,以及考虑时间是成功实施的关键.
- 这种方法并不普遍适用,并且有必须遵守的禁忌.
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K

